Recent advances in the tumor-penetrating peptide internalizing RGD for cancer treatment and diagnosis.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Recent advances in the tumor-penetrating peptide internalizing RGD for cancer treatment and diagnosis.
- Published In:
- Drug development research, 84(4), 654-670 (2023)
- Authors:
- Qian, Jing, Zhou, Sheng, Lin, Peng, Lei, Jin, Zheng, Shiqi, Xu, Wenmang, Wang, Yuanyuan, Gao, Ziran, Yang, Julun
- Database ID:
- RPEP-07295
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07295APA
Qian, Jing; Zhou, Sheng; Lin, Peng; Lei, Jin; Zheng, Shiqi; Xu, Wenmang; Wang, Yuanyuan; Gao, Ziran; Yang, Julun. (2023). Recent advances in the tumor-penetrating peptide internalizing RGD for cancer treatment and diagnosis.. Drug development research, 84(4), 654-670. https://doi.org/10.1002/ddr.22056
MLA
Qian, Jing, et al. "Recent advances in the tumor-penetrating peptide internalizing RGD for cancer treatment and diagnosis.." Drug development research, 2023. https://doi.org/10.1002/ddr.22056
RethinkPeptides
RethinkPeptides Research Database. "Recent advances in the tumor-penetrating peptide internalizi..." RPEP-07295. Retrieved from https://rethinkpeptides.com/research/qian-2023-recent-advances-in-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.